Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 83896 refers to a specific molecular diagnostic procedure that involves the use of nucleic acid probes. In this context, a molecular sequence is extracted from a tissue sample, which can be derived from various sources such as blood, biopsies, or other bodily fluids. The primary purpose of utilizing nucleic acid probes is to track and identify infectious diseases present within the extracted sample sequence. This technique is particularly valuable as it allows for the detection of genetic mutations that may indicate the presence of certain diseases, even in cases where the patient does not exhibit any symptoms. By analyzing the nucleic acids, healthcare professionals can gain insights into the genetic makeup of pathogens or the host's response, thereby facilitating early diagnosis and targeted treatment strategies. This procedure plays a crucial role in modern diagnostics, especially in the fields of oncology, infectious diseases, and genetic disorders.
© Copyright 2026 Coding Ahead. All rights reserved.
The procedure associated with CPT® Code 83896 is indicated for various clinical scenarios where the identification of infectious diseases or genetic mutations is necessary. The following conditions may warrant the use of this molecular diagnostic technique:
The procedure for CPT® Code 83896 involves several critical steps to ensure accurate molecular diagnostics. Each step is essential for the successful extraction and analysis of nucleic acids from the tissue sample.
After the completion of the procedure associated with CPT® Code 83896, the patient may not require extensive post-procedure care, as the process is typically minimally invasive. However, it is essential to monitor the patient for any immediate reactions to the sample collection. The results of the molecular diagnostic test will be communicated to the healthcare provider, who will discuss the findings with the patient and outline any necessary follow-up actions or treatments based on the results. Additionally, proper documentation of the procedure and results is crucial for compliance and future reference.
| Short Descr | MOLECULAR DIAGNOSTICS | Medium Descr | MOLECULAR DIAGNOSTICS | Long Descr | Molecular diagnostics; nucleic acid probe, each | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Discontinued Code | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. | CCS Clinical Classification | 233 - Laboratory - Chemistry and Hematology |
Get instant expert-level medical coding assistance.